SureChem
SureChEMBL is a free public chemical structure search platform operated by EMBL-EBI that provides searchable access to chemically annotated patents and small molecule data for academic and pharmaceutical researchers worldwide.
- Company typePrivate
- Founded-
- Headquarters—
- Headcount—
- GTM typeB2B
- OfferingSoftware
SureChem firmographics
Firmographics- Name
- SureChem
- Website
- https://surechembl.org
- Company type
- Private
- Operating status
- Operating
- Short description
- SureChEMBL is a free public chemical structure search platform operated by EMBL-EBI that provides searchable access to chemically annotated patents and small molecule data for academic and pharmaceutical researchers worldwide.
- Ownership category
- akta.pro rank
SureChem business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Operations
Revenue model
- Public Access (Free Resource): SureChEMBL is provided as a free public resource by EMBL-EBI, funded through institutional and governmental scientific research funding. No commercial revenue is generated from user access.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
SureChem product offering
Product offeringCore offering
SureChEMBL is a free, web-based chemical patent database that provides searchable access to all chemically annotated patent authorities and patents containing small molecules. The platform enables researchers to perform structure-based searches (substructure, similarity, identical, connectivity) alongside text searches across patent titles, abstracts, claims, and descriptions, with optional filtering by molecular weight and date ranges. Bulk chemically annotated patent data is additionally distributed via EMBL-EBI's FTP infrastructure.
Differentiator
Problem solved
Functional benefit
Companies that use SureChem
Customer profileSegments2 records
Ideal customer profiles2 records
SureChem technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
SureChem partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- EMBL-EBI (European Molecular Biology Laboratory - European Bioinformatics Institute)coreSureChEMBL is maintained and operated by EMBL-EBI as part of their suite of bioinformatics resources. EMBL-EBI provides the infrastructure, technical support, and institutional framework for the resource. The bulk data downloads are hosted on EMBL-EBI's FTP infrastructure (ftp.ebi.ac.uk).
Scale indicators1 record
SureChem competitors and assessment
Company assessmentDirect peers
- The Lens: Free public patent and scholarly knowledge database with chemistry search capabilities and patent landscape analytics. Directly comparable to SureChEMBL in offering free access to patent literature with chemical structure search, though with broader scope across all patent areas.
- ChEMBL: EMBL-EBI's drug discovery database focused on bioactive molecules with drug-like properties. Directly comparable to SureChEMBL in mission (chemistry data for life sciences research), public-access model, and shared EMBL-EBI infrastructure, though ChEMBL focuses on bioactivity data rather than patent literature.
- ChemSpider: Free chemistry database by the Royal Society of Chemistry aggregating chemical structures and associated literature data. Similar to SureChEMBL in free public-access model and chemical data aggregation, serving overlapping cheminformatics users in academic and industrial research.
- PubChem: Free public chemistry database operated by NCBI providing chemical information search across millions of compounds and related literature. Directly comparable to SureChEMBL as a free public cheminformatics resource serving the global research community, with broader scope beyond patents.
Broad incumbents
- IBM Watson for Drug Discovery: AI-powered drug discovery platform with patent analytics, literature mining, and chemical data integration. Broader incumbent offering enhanced chemical informatics with AI/ML capabilities, competing in adjacent drug discovery intelligence and modern enterprise workflows.
- Clarivate Derwent Innovation: Enterprise patent analytics platform with chemical indexing capabilities and broader IP intelligence workflows. Broader incumbent offering overlapping patent chemistry search and analytics at enterprise scale, competing in IP professional and pharmaceutical markets.
- Reaxys: Commercial chemistry database by Elsevier providing patent chemistry data, reaction information, and pharmacological data. Comparable in patent chemistry search functionality but with a commercial subscription pricing model and broader chemistry domain coverage.
- CAS SciFinder: Commercial chemistry research database from Chemical Abstracts Service covering patents, reactions, and literature. Broader commercial incumbent with overlapping capabilities in chemical patent search and cheminformatics, but operating on a paid subscription model rather than free public access.
Emerging players
- DrugBank: Comprehensive drug database providing chemical, pharmacological, and pharmaceutical data on FDA-approved drugs. Comparable in offering structured chemical data for drug discovery research, though more focused on approved drugs than patent literature specifically.
Market position
Customer concentration
SureChem social profiles
Digital presenceSureChem financial estimates
Financial estimateRevenue estimate
Valuation estimate
SureChem leadership team
Management profileNumber of profiles
SureChem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SureChem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SureChem
What does SureChem do?
SureChEMBL is a free, web-based chemical patent database that provides searchable access to all chemically annotated patent authorities and patents containing small molecules. The platform enables researchers to perform structure-based searches (substructure, similarity, identical, connectivity) alongside text searches across patent titles, abstracts, claims, and descriptions, with optional filtering by molecular weight and date ranges. Bulk chemically annotated patent data is additionally distributed via EMBL-EBI's FTP infrastructure.
Is SureChem a public or private company?
SureChem is a private company. It is currently operating.
When was SureChem founded?
SureChem was founded in -1.
How does SureChem make money?
One revenue line is on record: public Access (Free Resource).
Who are SureChem's main competitors?
Direct peers on record are The Lens, ChEMBL, ChemSpider and PubChem. Broad incumbents are IBM Watson for Drug Discovery, Clarivate Derwent Innovation, Reaxys and CAS SciFinder. DrugBank is listed as an emerging player.
Does SureChem have an API?
No public API is recorded for SureChem.